Beware of skin complications of newer antidiabetic agents

VANCOUVER, B.C. – Each of the newer classes of antidiabetic medications – the DPP-IV inhibitors, GLP-1 agonists, and SGLT2 inhibitors – has its own characteristic cutaneous side effects, Dr. Justin Endo said at the World Congress of Dermatology. These drugs aren’t first-line agents for patients...
Source: Skin and Allergy News - Category: Dermatology Source Type: news